FDA Accepts Application for Ropeginterferon Alfa-2b for Polycythemia Vera

[Manouche]

The FDA has accepted a Biologics License Application (BLA) for ropeginterferon alfa-2b (P1101) for use as a treatment for patients with polycythemia vera (PV) in the absence of symptomatic splenomegaly, according to PharmaEssentia Corporation, the manufacturer of the novel pegylated interferon.

onclive.com/web-exclusives/...

[hunter5582]

Thanks for posting. This is good news

[SoledadBarcelona]

What does P1101 mean?

Thanks

[saturn0325 in reply to SoledadBarcelona]

Code Besremi®

[robbjoy]

What about treatment for Essential Thrombocythemia Jak2+?